Original ArticlesSafety and Effectiveness of Bevacizumab-Containing Treatment for Non–Small-Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study
Key Words
Cited by (0)
The authors confirm that the material in this manuscript is original and has not been published in any other journal; however, interim data were presented at The 46th Annual Meeting of the American Society of Clinical Oncology on June 4–8, 2010, in Chicago, IL, and at The European Society for Medical Oncology on October 8–12, 2010 in Milan, Italy.
Disclosure: This study (NCT00388206) was sponsored by Genentech, Inc. Support for third-party writing assistance for this manuscript was provided by Genentech, Inc. The authors declare the following potential conflicts of interest: T.J.L. has served as a consultant for and received honoraria from F. Hoffmann-La Roche, Ltd.; J.G. has served as a consultant for and has received honoraria and research funding from Genentech, Inc.; M.J. has served as a consultant for and has received research funding from Genentech, Inc.; D.R.S., J.B., N.F., P.K., R.M.V., and A.J.W. have served as consultants for Genentech, Inc.; S.F., E.D.F., L.L., and S.J.H. are employees of Genentech, Inc.; and M.P.K. has served as a consultant for F. Hoffmann-La Roche, Ltd.